Augmentation index in patients with rheumatoid arthritis and ankylosing spondylitis treated with infliximab

Clinical Rheumatology

Volumn 29, Issue 7, 2010, Pages 723-727

  Pieringer, Herwig ^a   Stuby, Ulrike ^a   Pohanka, Erich ^a   Biesenbach, Georg ^a  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

Ankylosing spondylitis; Augmentation index; Infliximab; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; INFLIXIMAB; ANTIRHEUMATIC AGENT; BIOLOGICAL MARKER; MONOCLONAL ANTIBODY;

ADULT; ANKYLOSING SPONDYLITIS; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFECT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART MUSCLE PERFUSION; HEART WORK; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE WAVE; RADIAL ARTERY; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SUBENDOCARDIAL VIABILITY RATIO; TONOMETRY; ARTHRITIS, RHEUMATOID; BLOOD; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; DRUG EFFECTS; INFLAMMATION; MIDDLE AGED; RISK FACTOR; SPONDYLITIS, ANKYLOSING; STANDARD; TREATMENT OUTCOME; VASCULAR RESISTANCE;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; REFERENCE STANDARDS; RISK FACTORS; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME; VASCULAR RESISTANCE;

EID: 77956263250     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1388-4     Document Type: Article

References (23)

1. Doornum V, McColl G, Wcks IP (2002) Accelerated atherosclerosis. An extraarticular feature of rheumatoid arthritis? Arthritis Rheum 46:862-873
2. Klocke R, Cockcroft JR, Tylor GJ, Hall IR, Blake DR (2003) Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis 62:414-418
3. Pieringer H, Schumacher S, Schumacher S Suby U, Biesenbach G Semin Arthritis Rheum. 2009 Dec; 39(3):163-9. Epub 2008 Sep. 27
4. Peters MJ, van der Horst-Bruinsma IE, Djkmans BA, Nurmohamed MT (2004) Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 34:585-592
5. Sari I, Okan T, Okan T Aar S, Cece H, Altay C, Secil M, Birlik M, Onen F, Akkoc N (2006) Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology (Oxford) 45:283-286 (Pubitemid 43372841)
6. Wilkinson IB, MacCallum H, MacCallum H Roijmans DF, Murray GD, Cockcroft JR, McKnight JA, Webb DJ (2000) Increased augmentation index and systolic stress in type 1 diabetes mellitus. QJM 93:441-448
7. Brooks B, Molyneaux L, Molyneaux L Ye DK (1999) Augmentation of central arterial pressure in type 1 diabetes. Diabetes Care 22:1722-1727
8. Weber T, Auer J, O'Rourke MF, Kas E, Lassnig E, Berent R, Eber B (2004) Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 109:184-189
9. Weber T, Auer J, O'Rourke MF, Kas E, Lassnig E, Lamm G, Stark N, Rammer M, Eber B (2005) Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventions. Eur Heart J 26:2657-2663
10. Lipsky PE, van der Heijde DM, Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN, Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with Concomitant Therapy Study Group. N Engl J Med 343:1594-1602
11. Braun J, Brandt J, Lsting J, Zink A, Alten R, Golder W, Gromnica-Ihle E, Kellner H, Krause A, Schneider M, Sorensen H, Zeidler H, Thriene W, Sieper J (2002) Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 359:1187-1193
12. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126
13. Arnett FC, Edworthy SM, Boch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
14. van der Linden S, Valkenburg HA, Cts A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361-368
15. Wilkinson IB, MacCallum H, MacCallum H Fint L, Cockcroft JR, Newby DE, Webb DJ (2000) The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 525:263-270
16. Van Doornum S, McColl G, Wcks IP (2005) Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis. Rheumatology (Oxford) 44:1428-1432
17. Mäki-Petäjä KM, Hall FC, Both AD, Wallace SM, Yasmin BPW, Harish S, Furlong A, McEniery CM, Brown J, Wilkinson IB (2006) Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation 114:1185-1192
18. Hurlimann D, Forster A, Nll G, Enseleit F, Chenevard R, Distler O, Bechir M, Spieker LE, Neidhart M, Michel BA, Gay RE, Luscher TF, Gay S, Ruschitzka F (2002) Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 106:2184-2187
19. Gonzalez-Juanatey C, Testa A, Grcia-Castelo A, Garcia-Porrua C, Llorca J, Gonzalez-Gay MA (2004) Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody. Arthritis Rheum 51:447-450
20. Irace C, Mancuso G, Faschi E, Madia A, Sesti G, Gnasso A (2004) Effect of anti TNFalpha therapy on arterial diameter and wall shear stress and HDL cholesterol. Atherosclerosis 177:113-118
21. Matsui Y, Eguchi K, Sibasaki S, Ishikawa J, Hoshide S, Pickering T, Shimada K, Kario K (2008) Monitoring of the central pulse pressure is useful for detecting cardiac overload during antiadrenergic treatment: the Japan Morning Surge 1 study. J Hypertens 26:1928-1934
22. Kingwell BA, Waddell TK, Mdley TL, Cameron JD, Dart AM (2002) Large artery stiffness predicts ischemic threshold in patients with coronary artery disease. J Am Coll Cardiol 40:773-779
23. Chung ES, Packer M, L KH, Fasanmade AA, Willerson JT, Anti-TNF Therapy Against Congestive Heart Failure Investigators (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the Anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation 107:3133-3140